Bengaluru: The Karnataka Food Safety and Drug Administration (FDA) has seized medicines worth Rs 4,02,352 from two Amazon-linked facilities in Bengaluru Rural after officials found pharmaceutical stocks allegedly being stored without valid drug licences. The simultaneous raids were conducted by the department’s Drugs Enforcement Wing following intelligence inputs about violations in the storage and distribution of medicines.

The enforcement action was carried out at facilities in Thattanahalli in Anekal taluk and Aerospace in Devanahalli, with separate teams of drug-control officials conducting the inspections.

According to the FDA, the action was aimed at preventing unauthorised storage and distribution of medicines and ensuring that establishments involved in handling pharmaceutical products comply with licensing requirements.

Medicines worth Rs 2.45 lakh seized in Anekal

One of the raids was conducted at the premises of M/s Amazon Seller Services Pvt Ltd at Thattanahalli in Anekal taluk.

The team was led by Manohar, Assistant Drugs Controller (ADC), State Intelligence Branch, along with regional Drugs Inspectors.

During the inspection, officials found medicines allegedly stored at the premises without a valid drug licence. The FDA subsequently seized pharmaceutical stock valued at Rs 2,45,352.

The department said the operation was based on intelligence inputs regarding major compliance violations in the storage and distribution of medicines.

The seizure forms part of the state’s continuing efforts to check the handling of pharmaceutical products by e-commerce and other establishments.

Second raid conducted in Devanahalli

A separate team simultaneously conducted a raid at an Amazon facility in the Aerospace area of Devanahalli in Bengaluru Rural district.

The operation was led by Vibha, Drugs Inspector, Bengaluru Rural, along with other Drugs Inspectors.

Officials seized medicines valued at Rs 1,57,000 from the premises.

The FDA identified the facility as an unlicensed premises and said the action was taken as part of its enforcement drive against unauthorised storage and distribution of pharmaceutical products.

The two seizures together amounted to Rs 4,02,352.

FDA focuses on drug licensing compliance

Drug licences are an important regulatory requirement for establishments involved in the storage and distribution of medicines. The licensing system allows authorities to monitor the handling of pharmaceutical products and check whether prescribed storage and distribution conditions are being followed.

The latest raids indicate that the Karnataka FDA is increasing scrutiny of e-commerce-linked pharmaceutical storage facilities.

The department said its action was specifically intended to prevent unauthorised storage and distribution and ensure compliance with drug licensing requirements.

The seizures do not, by themselves, establish that the medicines were counterfeit, substandard or unsafe. The reported violation concerns the alleged absence of the required drug licence for storage at the premises.

E-commerce medicine sales under greater scrutiny

The action comes amid growing regulatory attention on the online sale and distribution of medicines.

E-commerce platforms have become an increasingly important channel through which consumers access healthcare products. At the same time, regulators have been examining how medicines are stored, supplied and sold through online platforms and their associated warehouses and seller facilities.

The latest Karnataka FDA operation highlights the importance of ensuring that medicines moving through such supply chains are handled by appropriately licensed entities.

The department’s enforcement activity is also relevant to consumer safety because improper storage conditions can potentially affect pharmaceutical products, depending on the type of medicine and its storage requirements.

Amazon facilities face regulatory scrutiny

The facilities raided in the latest operation were linked to Amazon, but the FDA’s action was focused on the alleged licensing violations identified at the premises.

There was no immediate response from Amazon regarding the seizures in the reports available at the time of publication.

The enforcement action should therefore not be interpreted as a finding that all medicines sold through Amazon are unauthorised or that the platform as a whole has violated drug laws.

The investigation and any subsequent regulatory proceedings will determine the precise nature of the violations and responsibility for the storage of the seized medicines.

Karnataka FDA continues enforcement drive

The latest seizures come amid a broader enforcement drive by Karnataka’s food and drug authorities against violations involving food and pharmaceutical products.

The FDA has recently carried out inspections at several establishments across Bengaluru and other parts of Karnataka, with officials checking compliance with licensing, storage and safety requirements.

The department’s action at the two Amazon-linked premises demonstrates that e-commerce-linked facilities are also coming under scrutiny where medicines are stored or distributed.

Further regulatory action could follow based on the findings of the inspections and the applicable provisions of drug-control laws.

Conclusion

The Karnataka FDA has seized medicines worth Rs 4.02 lakh from two Amazon-linked facilities in Anekal and Devanahalli after alleging that pharmaceutical stocks were being stored without valid drug licences.

While the seizures highlight regulatory concerns surrounding the storage and distribution of medicines through e-commerce-linked facilities, they do not establish that the seized medicines were counterfeit or unsafe. The focus of the reported action was on alleged licensing violations.

The case underlines the need for proper regulatory compliance throughout the online pharmaceutical supply chain, from storage and distribution to final delivery to consumers.